Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Quinoline-galactose hybrids bind selectively with high affinity to a galectin-8 N-terminal domain

  • Kumar Bhaskar Pal
  • Mukul Mahanti
  • Xiaoli Huang
  • Stella Persson
  • Anders P. Sundin
  • Fredrik R. Zetterberg
  • Stina Oredsson
  • Hakon Leffler
  • Ulf J. Nilsson
Publishing year: 2018-08-03
Language: English
Pages: 6295-6305
Publication/Series: Organic and Biomolecular Chemistry
Volume: 16
Issue: 34
Document type: Journal article
Publisher: Royal Society of Chemistry

Abstract english

Quinolines, indolizines, and coumarins are well known structural elements in many biologically active molecules. In this report, we have developed straightforward methods to incorporate quinoline, indolizine, and coumarin structures into galactoside derivatives under robust reaction conditions for the discovery of glycomimetic inhibitors of the galectin family of proteins that are involved in immunological and tumor-promoting biological processes. Evaluation of the quinoline, indolizine and coumarin-derivatised galactosides as inhibitors of the human galectin-1, 2, 3, 4N (N-terminal domain), 4C (C-terminal domain), 7, 8N, 8C, 9N, and 9C revealed quinoline derivatives that selectively bound galectin-8N, a galectin with key roles in lymphangiogenesis, tumor progression, and autophagy, with up to nearly 60-fold affinity improvements relative to methyl β-d-galactopyranoside. Molecular dynamics simulations proposed an interaction mode in which Arg59 had moved 2.5 Å and in which an inhibitor carboxylate and quinoline nitrogen formed structure-stabilizing water-mediated hydrogen bonds. The compounds were demonstrated to be non-toxic in an MTT assay with several breast cancer cell lines and one normal cell line. The improved affinity, selectivity, and low cytotoxicity suggest that the quinoline-galactoside derivatives provide an attractive starting point for the development of galectin-8N inhibitors potentially interfering with pathological lymphangiogenesis, autophagy, and tumor progression.


  • Biochemistry and Molecular Biology


  • ISSN: 1477-0520
Stina Oredsson
E-mail: stina [dot] oredsson [at] biol [dot] lu [dot] se


Functional zoology

+46 46 222 94 97



Principal investigator

LUCC - Lund University Cancer Centre

Research group

Animal Physiology


Cell proliferation

Doctoral students and postdocs

PhD Students, main supervisor

Wendy Soria Sotillo

PhD Students, assistant supervisor

Atena Malakpour Permlid